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Abstract: Several collagen subtypes have been identified in hyaline articular cartilage. The main and 
most abundant collagens are type II, IX and XI collagens. The minor and less abundant collagens 
are type III, IV, V, VI, X, XII, XIV, XVI, XXII, and XXVII collagens. All these collagens have been 
found to play a key role in healthy cartilage, regardless of whether they are more or less abundant. 
Additionally, an exhaustive evaluation of collagen fibrils in a repaired cartilage tissue after a chon-
dral lesion is necessary to determine the quality of the repaired tissue and even whether or not this 
repaired tissue is considered hyaline cartilage. Therefore, this review aims to describe in depth all 
the collagen types found in the normal articular cartilage structure, and based on this, establish the 
parameters that allow one to consider a repaired cartilage tissue as a hyaline cartilage. 
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1. Introduction 
Collagens are the most abundant proteins in mammals accounting for approximately 
30% of total protein mass [1]. More than two-thirds of the dry weight of adult articular 
cartilage, over three-fourths of the dry weight of human skin, over 90% of human tendon 
and corneal tissues, and almost 80% of the organic matter in bones are composed of col-
lagen, a major component of connective tissues [2,3]. Collagen is approximately 60% of 
the dry weight of hyaline cartilage, being the main protein in the cartilage extracellular 
matrix (ECM) composition [4,5]. Since the discovery of the first collagen [6], more than 26 
new collagens have been revealed [1,7–10].  
In articular cartilage, characterized by having a hyaline structure, numerous sub-
types of collagens have been identified. The main, most abundant collagens, which are 
mostly studied by researchers are type II, IX, and XI collagens [11,12]. Type III, IV, V, VI, 
and X collagens are less abundant in cartilage, which is why some authors highlight them 
and others do not [11–13]. Even so, the presence of these minor collagens in healthy artic-
ular cartilage is reliable. However, the quantity of some of these minor collagens in 
healthy cartilage is still controversial. In addition, some researchers mentioned that type 
XII, XIV, XVI, XXII, and XXVII collagens are also part of articular cartilage [13], although 
the information given about them is very brief. As well as all the collagens mentioned 
above, type I collagen can sometimes be found in articular cartilage. However, this should 
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not occur in healthy articular cartilage as it indicates the presence of fibrotic connective 
tissue [14]. 
When a chondral defect is treated, an attempt is made to repair the tissue by making 
the characteristics of the new cartilage as similar as possible to normal hyaline cartilage. 
To assess the effectiveness of the treatment that has been used, it is necessary to assess the 
quality of the repaired tissue, and for this purpose we need to establish a threshold that 
allows us to identify the repaired cartilage as hyaline cartilage. Moreover, it is essential to 
conduct a study of the collagens present in the repaired cartilage tissue to conduct a good 
assessment of the quality of the chondral repair. 
Therefore, the purpose of this review is to describe in detail all of the collagens that 
can be found in articular cartilage, as well as describe collagen fibrils assessment consid-
erations in order to identify repaired hyaline cartilage in chondral defects. 
2. Articular Cartilage 
Hyaline articular cartilage is a highly specialized connective tissue, whose main func-
tion is to provide a smooth and lubricated surface for the joint and to facilitate the trans-
mission of loads with a low coefficient of friction [15–17]. Articular cartilage is composed 
of hyaline tissue including a dense ECM with a low distribution of chondrocytes [18]. 
Unlike most tissues, it lacks blood vessels, lymphatics and nerves, and in addition, its cells 
have a low replication potential, so the cartilage repair capacity is limited [19–21]. 
ECM consists of interlocking mesh of water, collagens, and proteoglycans (PG), as 
well as smaller amounts of non-collagen proteins. All components combined generate a 
single viscous material, optimized to support loads [15,22]. Chondrocytes are the only 
highly specialized cells found in cartilage that constitute between 1–5% of cartilage vol-
ume. These cells play a pivotal role providing mechanical support [11,23]. 
2.1. Cartilage Zones 
Adult cartilage has an architecture divided into zones (Figure 1-A), which vary de-
pending on the biochemical composition of ECM, cell density and morphology, and cel-
lular and ECM metabolism [24].  
 
Figure 1. Masson’s trichrome staining of a representative section of healthy hyaline cartilage. (A) Cartilage zones. (B) 
Regions of the ECM. 
The surface zone is the outermost and thinnest of all layers and constitutes approxi-
mately 10% to 20% of the thickness of the joint cartilage. It is composed of a relatively high 
number of oval shaped chondrocytes parallel to the surface of the joint. Chondrocytes in 
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this area synthesize a high concentration of collagen and a low concentration of proteo-
glycans. This zone has the highest water content. The collagen fibers in this zone are heav-
ily packaged and are also aligned parallel to the joint surface, to provide the greatest re-
sistance to traction and shear. The superficial zone is in contact with synovial fluid and is 
responsible for most of the traction properties of cartilage [11,15,19,25,26]. 
Immediately underneath the surface zone is located the middle or transition zone, 
which provides an anatomical and functional bridge between the superficial and deep 
zones. The middle zone represents 40% to 60% of the total volume of cartilage and con-
tains thicker PG and collagen fibrils. In this zone, collagen is organized obliquely, and 
chondrocytes are spherical and have low density. Fundamentally, the middle zone is the 
first line of resistance to compression forces [11,15,19,25,26]. 
Then, the deep zone involves the connection between the cartilage tissue and sub-
chondral bone. The deep zone is responsible for providing the greatest resistance to com-
pression forces since the collagen fibrils are arranged perpendicular to the joint surface. 
This zone contains the largest diameter collagen fibrils in radial arrangement, the highest 
content of PG and the lowest concentration of water. Chondrocytes are larger and are 
usually available in a columnar orientation, parallel to the collagen fibers and perpendic-
ular to the surface. The deep zone represents approximately 30% of the joint cartilage vol-
ume. Between the deep zone and the calcified cartilage, we find the tidemark that distin-
guishes both areas [11,15,19,25,26]. 
The calcified cartilage zone plays an integral role in the fixation of cartilage to the 
bone by anchoring collagen fibrils from the deep zone to the subchondral bone. In this 
zone, the cell population is scarce, and chondrocytes are hypertrophic, which makes met-
abolic activity very low [11,15,19,25,26]. 
2.2. Regions of the Extracellular Cartilage Matrix 
In addition to the zoned architecture, the matrix consists of several regions. The ECM 
can be divided into three regions, depending on the proximity to chondrocytes, the com-
position, the diameter, and organization of collagen fibrils: pericellular, territorial and in-
terterritorial (Figure 1-B) [15]. The pericellular matrix (PCM) is a thin layer adjacent to the 
cell membrane that completely surrounds the chondrocyte, playing an important role in 
the transduction of signals and other aspects of cartilage [24]. The territorial matrix sur-
rounds the PCM, this being thicker and protecting the cartilage cells against mechanical 
stress. In addition, it contributes to the elasticity of the cartilage structure and its ability to 
withstand loads. The interterritorial matrix is the biggest, contributing more to biome-
chanical properties of articular cartilage [11,15,23]. 
3. Collagens 
Collagen is the major ECM molecule that self assembles into cross striated fibrils, 
provides support for cell growth and is responsible for the mechanical resilience of con-
nective tissues. To date, between 28 and 29 types of collagens have been described [27–
29]. 
Collagen belongs to the family of glycoproteins that are characterized by signature 
features. Each polypeptide chain has a repeating sequence of amino acids [Gly-X-Y]n, 
with and without interruptions (those with interruptions contain numerous residues). 
Furthermore, the X and Y positions are frequently occupied by proline and its hydrox-
ylated form, 4-hydroxyproline, respectively. Finally, the right-handed tripe helix is 
formed from three left-handed polyproline α-chains of identical length, which gives col-
lagen a unique quaternary structure [8,9,27,30]. 
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3.1. Biosynthesis of Collagens Fibers 
Collagen fibrils biosynthesis begins with the genetic transcription of genes (Figure 2-1) 
within the nucleus to the aggregation of collagen heterotrimers into large fibrils [31]. 
 
Figure 2. Schematic representation of collagen biosynthesis. (1) Gene transcription. (2) Formation of α-chains. (3) For-
mation of triple helix procollagen and secretion into extracellular space. (4) Procollagen processing and formation of tro-
pocollagen. (5) Association of tropocollagen molecules to form collagen structures. 
Inside the rough endoplasmic reticulum (RER), the assembly of mainly three amino 
acids (glycine, proline or its derivative hydroxyproline, and lysine) gives rise to the for-
mation of polypeptide chains (α chains) (Figure 2-2). In the Golgi, three of these α chains 
are assembled one around the other, along a central axis, to generate a procollagen mole-
cule in the form of right-handed triple-helix (Figure 2-3) [32,33].  
Subsequently, procollagen is secreted into the extracellular space, giving rise to tro-
pocollagens units (Figure 2-4). Once in the extracellular space, molecular processing is 
different depending on the type of collagen in question and the supramolecular structure 
that it must form in a tissue. In general, in the extracellular space, several tropocollagen 
molecules associate to form fibrils and fibers (Figure 2-5) [31,32,34]. 
3.2. Classification of Collagen Types 
Collagens can be grouped based on their structure, function, and tissue distribution. 
They are designated by Roman numerals according to the order of their discovery and 
Greek letters to identify the chains, bands, and higher molecular weight components. 
There are homotrimers, formed by three identical chains, or heterotrimers, formed by 
two/three different chains [27,32,35].  
The different types of collagens and their structure are crucial to provide mechanical 
stability, elasticity, and strength to tissues and organs. Following a classification based on 
collagen function and composition, several groups are distinguished (Figure 3): (1) Fibril-
forming collagens; (2) Fibril-associated collagens with interrupted tripled helices; (3) Col-
lagens forming networks; (4) Transmembrane collagens; (5) Multiplexins; (6) Anchor fi-
bers; and (7) Beaded filament-forming collagens [9,32]. 
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(1) The classical fibril-forming collagens include types I, II, III, V and XI collagens. 
They are characterized by appearing as periodic fibrils with an indeterminate in length, 
depending on the tissue and developmental stage, and range in diameter from 12 nm to 
500 nm [36]. All fibril-forming collagens are composed of a large continuous triple helix 
bordered by the N- and C-propeptide referred as the NC1 domain. The N-propeptide is 
divided into sub-domains: a short sequence (NC2) that links the major triplex helix to the 
minor one, and a globular N-terminal end (NC3) [8]. This collagen is the most abundant 
collagen in vertebrates, and it plays a structural role by contributing to the molecular ar-
chitecture, shape and mechanical properties of tissues [37]. 
(2) The types IX, XII, XIV, XVI, XIX and XX collagens belong to the fibril-associated 
collagens with interrupted tripled helices (FACITs). They are relatively short collagens, 
with interruptions in the triple helical domain and can be found at the surface of collagen 
fibrils. These molecules are mostly heterotrimers and carry a glycosaminoglycan side 
chain [8,31]. These collagens are involved in the integrity and stability of the ECM, mod-
ulating the formation and size of the collagen fibrils and controlling cellular organization 
in the ECM [38]. 
(3) Collagens forming networks are longer than classical fibril-collagens and can give 
rise to different kinds of networks depending on the collagen type [10]. These collagens 
include collagen types IV, VI, VIII and X. They are non-fibrillar collagens that aggregate 
linearly or laterally to form open networks. The collagen networks act as supporting struc-
tures for cells and tissues, serve as selective molecular filters and barriers and function as 
anchor for neighboring cells [39]. 
(4) The group of transmembrane collagens (MACITs) is comprised of type XIII, XVII, 
XXIII and XV collagens. These collagens are homotrimers of an α-chain which contains an 
N-terminal intracellular domain, a hydrophobic transmembrane stretch, and a large ex-
tracellular C-terminus. All members of this group are also shed from the cell surface, gen-
erating soluble forms. They are found in numerous cell types and stand out for its cell 
adhesive properties [10,40].  
(5) Type XV and XVIII collagens are multiplexins that are non-fibrillar collagens and 
have multiple interruptions within its collagenous domain enabling more structural flex-
ibility [41]. These collagens occur in the epithelial and endothelial basement membrane 
zones of a wide variety of tissues. Their biological roles are essentially separate, that of 
collagen XV in the muscle and that of collagen XVIII in the eye [8]. 
(6) Type VII collagen is the main constituent of the anchoring fibrils, structures that 
mediate the adhesion of the epidermis onto the dermis. It consists of a central collagenous 
triple-helical domain flanked by NC1 and NC2 domains [42,43]. 
(7) Type VI collagen is the archetypal beaded filament-forming collagen. It is widely 
expressed and holds up tissue integrity. Collagen VI monomers are made up of short tri-
ple helical domains, which aggregate linearly to form beaded filaments or laterally 
through their globular domains, thus creating 3D networks [44,45]. 




Figure 3. Classification of collagen types based on their structural and organisation. 
4. Types of Collagens in Articular Cartilage 
There are numerous subtypes of collagens in the articular cartilage (Table 1). In 
healthy joint hyaline cartilage, there are main collagens (type II, IX, and XI collagen) and 
minor collagens (type III, IV, V, VI, X, XII, XIV, XVI, XXII, and XXVII collagens). In artic-
ular cartilage with any damage or pathology type I collagen could be found. 
Table 1. Types of collagens that may be present in articular cartilage. 




Distribution in the 
Human Body 






Bone, skin, cornea, and 
many interstitial 
connective tissues with 
the exception of hyaline 
cartilage, brain and 
vitreous body. 
Type II [α1(II)]3 COL2A1 
Fibrill-forming 
collagen 
90–95% ECM of all zones 
Cartilage, vitreous, and 
intervertebral disc. 




Bloods vessels, uterus, 































Adipose tissue, skeletal 
muscle, cartilage, 
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pancreatic islets, skin, 
















Skin, cornea, blood 
vessels, heart, lung, 
adipose tissue, nervous, 
pancreas, bone, 
cartilage, and muscle. 





ECM of all zones 
and growth plate 
in adults 
Cartilages, eye vitreum, 
avian cornea, ear, and 
intervertebral disc. 









and the calcified zone. 







ECM of all zones 
and PCM 
Cartilage, tendons, 
trabecular bone, testis, 
trachea, skeletal muscle, 
placenta, ovarian, lung, 
and brain. 
*: percentage of collagen in healthy articular cartilage; ECM: extracellular matrix; PCM: pericellular matrix; FACIT: fibril-
associated collagens with interrupted triple helices. n/a: no studies have been found to support it. 
4.1. Main Collagens of Healthy Articular Cartilage 
4.1.1. Type II Collagen 
Type II collagen is a homotrimeric molecule of three α1(II) chains, encoded by the 
COL2A1 gene, and mainly synthesized by chondrocytes and nucleus pulposus cells 
[46,47]. It is expressed, synthesized, and secreted into the ECM as two isoforms (IIA and 
IIB). These isoforms are generated in a developmentally regulated manner by alternative 
splicing of exon 2. Chondroprogenitor cells synthesize predominantly IIA isoforms (con-
taining exon 2), while differentiated chondrocytes produce mainly IIB transcripts (devoid 
of exon 2) [46,48]. 
Type II collagen is a fibrillar collagen that is restricted to cartilages, vitreous and in-
tervertebral discs [49]. The mature articular cartilage comprises more than 90–95% of car-
tilage collagen. Type II and type XI collagen co-polymerize with type IX collagen to form 
a heteropolymeric fibrillar framework that gives cartilage its tensile strength [3,50,51].  
Type II collagen, together with other proteins and PG, can form complex extracellular 
scaffolds to bear mechanical forces, maintain physiological homeostasis, and provide an-
choring sites for chondrocytes, ECM molecules, and growth factors. Degradation and re-
duction of type II collagen are frequently observed in osteoarthritic cartilage. The type II 
collagen decrease in osteoarthritic cartilage is thought to be caused by chondrocyte hy-
pertrophy. In addition to its structural function, type II collagen is an important extracel-
lular signaling molecule that can regulate chondrocytes proliferation, metabolism, and 
differentiation, similar to soluble signals [52]. 
4.1.2. Type IX Collagen 
Type IX collagen is a heterotrimer composed of α1(IX), α2(IX) and α3(IX) chains en-
coded by genes COL9A1, COL9A2 and COL9A3, respectively, and belong to the group of 
FACITs collagens [53,54]. 
This collagen is found mostly in cartilages, but it also occurs in the eyes, ear, and 
intervertebral discs, always in co-existence with type II collagen [55]. 
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In regard to articular cartilage, type IX collagen constitutes 1% to 5% of total collagen 
in adult humans and 10% of that in fetus. It is proposed to stabilize the fibrillar and pro-
teoglycan networks via lateral association with type II and type XI collagen [3,13,56]. 
Several studies showed that type IX collagen may play important roles in the patho-
genesis of arthritis diseases, the formation of a stable collagen network and in the mainte-
nance of cartilage organization and integrity [57,58]. Loss of type IX collagen in aging ar-
ticular cartilage may results in a weaker matrix that is more susceptible to degradation 
[59]. In addition, type IX collagen mutations in human have been linked with the autoso-
mal dominant diseases, multiple epiphyseal dysplasia, characterized by short stature and 
severe joint pain caused by early onset of osteoarthritis (OA) [59]. Therefore, type IX col-
lagen is crucial for the maintenance of cartilage matrix and formation of collagen mesh-
work [3,13,53]. The reduced level of type IX collagen may contribute to the pathogenesis 
of osteoarthritis [13]. 
4.1.3. Type XI Collagen 
Type XI collagen is composed of three α-chains, α1(XI), α2(XI), and α3(XI), which are 
encoded by COL11A1, COL11A2, and COL2A1, respectively [60]. The α3(XI) chain of type 
XI procollagen and the α1(II) chain of type II procollagen are encoded by the same gene, 
being α3(XI) chain, an over-hydroxylated version of α1(II) [46,61].  
This collagen is a cartilage-specific ECM protein important for cartilage collagen fibril 
formation and for ECM organization, but it is also broadly distributed in tendons, trabec-
ular bone, testis, trachea, skeletal muscle, placenta, ovarian, lung and the neoepithelium 
of the brain [60,62,63]. 
In fetal cartilage, type XI collagen represents around 10% of total collagen, while in 
adult human cartilage its presence decreases to 3% [12]. In fetal cartilage, type XI collagen 
consists of molecules containing three genetically distinct chains α1(XI), α2(XI), and 
α3(XI) in a 1:1:1 ratio. However, from mature articular cartilage, purified type XI collagen 
also includes about equal amounts of α1(V) and α1(XI) chains, suggesting the existence of 
type V/XI hybrid molecules in the matrix [64]. 
In cartilage, type XI collagen is a minor component of collagen fibrils, but it is essen-
tial for the interaction between PG aggregates and collagens [60]. It is polymerized to form 
the core of type II collagen fibrillogenesis and regulates type II fibril diameters in the car-
tilage [46]. Type XI collagen molecules are found in thin cartilage fibrils composed of four 
micro-fibrils, two of which are type II collagen and two of which are type XI collagen, 
surrounded by ten type II micro-fibrils [65]. 
Type XI collagen is the first cartilage collagen deposited by mesenchymal stem cells 
undergoing chondrogenic differentiation [66], suggesting its involvement in the regula-
tion of cartilage formation [67]. It is preferentially retained at the chondrocyte surface and 
involved in the organization of the PCM via interaction with cartilage PG [13]. 
Mutations in type XI collagen cause various types of chondrodysplasias which are 
known as “type XI collagenopathies.” Some of these chondrodysplasias in human include 
Stickler syndrome type II, Marshall syndrome, and oto-spondylo-megaepiphyseal dys-
plasia [13,64,67]. Furthermore, it has been shown that a type XI collagen mutation results 
in increased degradation of type II collagen in articular cartilage [13]. 
4.2. Minor Collagens of Healthy Articular Cartilage 
4.2.1. Type III Collagen 
Type III collagen is a homotrimer of three α1(III) chains, which are encoded by 
COL3A1 gene [49]. 
This collagen is the second most abundant collagen type in human body, classified 
as one of the major fibrillar collagens. It constitutes about 5–20% of the entire collagen 
content in the human body [68,69]. Type III collagen is found as a major structural com-
ponent in hollow organs such as large bloods vessels, uterus and bowel, tissues that must 
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withstand stretching. It is also found as a copolymer with type I collagen in many tissues, 
including skin, tendon, ligament, vascular walls, periodontal ligament, and synovial 
membranes [70]. 
Type III collagen provides tensile strength and integrity for many organs, but also 
other different functions has been reported for this collagen. One of the earliest studies on 
type III collagen, carried out by Balleisen et al. [71], showed that it influences the aggre-
gation of human platelets. Subsequent studies showed that the platelets interact with type 
III collagen through specific glycoproteins [72,73]. Type III collagen also functions in cell 
adhesion, migration, proliferation, and differentiation through its interaction with integ-
rins [70]. 
Regarding the role that type III collagen plays in cartilage, there are some controver-
sies, because we can find it both in healthy cartilage and in aged or osteoarthritic cartilage. 
Thus, the content of type III collagen could vary markedly at different stages of develop-
ment and disease. Some studies confirmed that a small but significant amount of type III 
collagen becomes deposited in articular cartilage of mature joints, concentrated in the ma-
trix surrounding chondrocytes throughout the depth of the tissue and particularly prom-
inent in human osteoarthritic joints [74,75]. According to Hosseininia et al. [76], type III 
collagen in the human articular cartilage increases in the territorial matrix of aging indi-
viduals, although it remains unclear whether this increase represents a protective re-
sponse to cartilage degeneration or a contributor to the pathological process. Moreover, 
in human OA, type III collagen is significantly up-regulated in cartilage [76]. Another 
study revealed that type III collagen is found in the adult human cartilage, and it has been 
suggested that its role is to act as a modifier of the fibril network composed of type II 
collagen together with other minor collagens during tissue healing [49,70]. Wang et al. 
showed that type III collagen is a crucial matrix constituent for the establishment of nor-
mal cartilage ECM [68]. 
Mutations in the COL3A1 gene cause the vascular type of Ehlers-Danlos syndrome, 
which is a rare, life-threatening genetic disease. Other disease phenotypes associated with 
COL3A1 include a brain abnormality characterized by frontoparietal polymicrogyria, and 
many fibrotic diseases [70]. 
4.2.2. Type IV Collagen 
Type IV collagen has a triple-helical structure composed of 3 of 6 different α- chains 
(α1, α2, α3, α4, α5, and α6) encoded by COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, 
and COL4A6. These helical polypeptide α-chains form triple-helical isoforms, which only 
3 have been identified: α1(IV)α1(IV)α2(IV) or (α112), α3(IV)α4(IV)α5(IV) or (α345), and 
α5(IV)α5(IV)α6(IV) or (α556). They are assembled into three major networks (α112:α112, 
α112:α556, α345:α345), interconnected by NC1 domain [29,77–79].  
This collagen is identified primarily in the skin, is the most important structural com-
ponent of basement membranes [31,80]. α1 and α2 chains are expressed ubiquitously in 
basement membranes, although type IV collagen α3, α4, α5, and α6 chains have a tissue 
specific distribution [80]. The α3α4α5 network has mainly been identified in lung alveoli, 
kidney, testis, cochlea, and eye, whereas the α5α5α6 network has been located in skin, 
smooth muscle cells, oesophagus, and Bowman´s capsule of the kidney [29,81]. 
Regarding cartilage, type IV collagen is observed in the PCM of healthy cartilage tis-
sues but generally absent in degenerated and fibrotic cartilage tissues [79], although there 
is evidence that it can be found in PCM of degenerative hyaline cartilage [82]. It was ob-
served that type IV collagen was in both in vitro engineered cartilaginous constructs and 
in vivo cartilage repair samples, in addition they shown that chondrocytes were capable 
of synthesizing type IV collagen [82]. 
The specific isoform of type IV collagen α112(IV) was identified as the unique type 
in articular cartilage. This isoform contains arrestenand canstatin that are anti-angiogenic 
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protein fragments. Since articular cartilage is an avascular structure, type IV collagen iso-
form α112(IV) with their unique anti-angiogenic properties might be involved in the tem-
poral control of vascularization during cartilage repair and in cartilage homeostasis [79]. 
Mutations in type IV collagen α3 to α6 chains causes Alport´s syndrome associated 
with glomerulonephritis, sensorineural deafness and eye abnormalities [80,81]. 
4.2.3. Type V Collagen 
The collagen type V triple helix is formed as a heterotrimer by one α1(V) chain and 
two α2(V) chain, which are encoded by COL5A1 and COL5A2 genes. It is widely distrib-
uted in tissues as α1(V)2α2(V) that integrate into fibrils of the abundant type I collagen 
and regulate the geometry of resulting col(I)/col(V) heterotypic fibrils [83,84]. There is a 
third col(V) chain, α3(V), which can be found in α1(V)α2(V)α3(V) heterotrimers and has 
more limited tissue distribution than α1(V)2α2(V) heterotrimers. Tissues in which the 
α3(V) chain have been detected in white adipose tissue, skeletal muscle, and pancreatic 
islets, where these chains are important for proper functioning of the adipocytes, myofi-
bers, and pancreatic β cells, respectively [84,85]. 
This collagen is classified as a minor fibrillar collagen that under normal physiologic 
conditions assembles into heterotypic fibrils with the major fibrillar collagen type I [86], 
although it can also be found assembled as type V/XI collagen [87]. 
Despite being a minor collagen, type V collagen is an abundant protein in skin, pla-
centa and lung, and essential for tissue elasticity and compliance [88]. Type V collagen 
plays a basic function in the formation of fibrillar collagen mesh and has an important role 
in fibrogenesis control or fiber size regulation. Furthermore, the type V collagens contrib-
ute to the linking between stromal collagen and basement membrane, being important for 
cellular adhesion and matrix-repairing process [89].  
As regards to articular cartilage, D.R. Eyre and J.J. Wu. [50], isolated mature articular 
cartilage, where type XI collagens included a significate pool of α1(V) chains which im-
plied the presence of V/XI hybrid molecules. Later, a study carried out by J.J. Wu et al. 
[87], proved the presence of V/XI hybrid molecules in articular cartilage showing an accu-
mulation of collagen α1(V) chains as articular cartilage matures. Although it has been 
shown that the type V collagen is present in articular cartilage [90], no studies have been 
found that discuss its role in articular cartilage.  
One of the main diseases associated with a defect in type V collagen is classic Ehlers-
Danlos syndrome. It is a rare autosomal dominant connective tissue disorder that is pri-
marily characterized by skin hyperextensibility, abnormal wound healing/atrophic scars, 
and joint hypermobility [91]. 
4.2.4. Type VI Collagen 
Type VI collagen is a heterotrimer that has a characteristic beaded filamentous struc-
ture of tetrameric units that consists of three different α-chains, α1(VI), α2(VI), and α3(VI), 
which are encoded by the genes COL6A1, COL6A2, and COL6A3. Recently, 3 novel subu-
nits of type VI collagen are revealed, α4(VI), α5(VI), and α6(VI) chains encoded by the 
COL6A4, COL6A5, and COL6A6 genes, which are highly homologous to the α3(VI) chain 
[92–94]. 
This collagen is found in almost all tissue and distributed among tissues such as skin, 
cornea, blood vessels, heart, lungs, adipose tissue, nervous tissues, pancreas, bones, carti-
lage, and muscle [45,92,93]. 
There is a high affinity between collagen VI and numerous ECM components, as bi-
glycan, decorin, hyaluronan, fibronectin, perlecan and heparin, as well as with the cell 
membrane. Thus, type VI collagen has been hypothesized to play an essential role in me-
diating cell-matrix interactions as well as intermolecular interactions in various tissues 
[95]. In addition, this collagen participates in the maintenance of tissue integrity creating 
cell-matrix and matrix-matrix interactions [96]. 
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In some studies, total type VI collagen, a putative marker of mesenchymal activation, 
has been suggested to be an indicator of early architectural remodeling in liver fibrosis 
[97,98]. 
In skeletal muscle, type VI collagen is present in the ECM where it functions to anchor 
the basement membrane to underlying interstitial tissues [99]. Mutations in the COL6A1, 
COL6A2, and COL6A3 genes lead to a continuous spectrum of disorders characterized by 
muscle weakness and connective tissue abnormalities [100]. These mutations have been 
identified as causative in Ullrich congenital muscular dystrophy, Bethlem myopathy and 
myosclerosis myopathy [45,101]. 
In articular cartilage, type VI collagen is present in small amounts (1–2%) forming a 
network that anchors the chondrocytes to the PCM through its interaction with a wide 
variety of ECM proteins, including type II collagen, type XIV collagen, cartilage matrix 
protein or matrilin-1, hyaluronan, decorin, and fibronectin; which implies the attachment 
and integrity of chondrocytes [13,95,102]. 
In normal adult human articular cartilage, the PCM is typically defined by the exclu-
sive presence and localization of type VI collagen around the chondrocytes [24]. Some 
studies confirm that type VI collagen could contribute to PCM structural integrity and 
mechanical properties. Furthermore, it may serve as a filter or transducer for biochemical 
and/or biomechanical signals from the cartilage ECM [13,95]. 
Studies conducted in mice showed that those with type VI collagen deficiency exhib-
ited accelerated development of hip OA, a delayed secondary ossification process, in-
creased chondrocyte swelling and a loss of the stiffness of the articular cartilage PCM. 
These finding suggest that type VI collagen plays an essential role in transmitting me-
chanical and osmotic stresses from the ECM to the chondrocytes [95,103]. 
4.2.5. Type X Collagen 
Type X collagen is a homotrimeric collagen which consists of three identical α1(X) 
chains, encoded by the COL10A1 [104,105].  
This collagen is a specific collagen in cartilage. It constitutes about 1% of total colla-
gen in adult human articular cartilage [13]. It is synthesized by hypertrophic chondrocytes 
during enchondral bone formation and is found exclusively in the hypertrophic cartilage 
and the calcified zone of articular cartilage [106]. Thus, the 45% of the total collagens pro-
duced by mature hypertrophic chondrocytes are type X [104]. As the most widely used 
marker for chondrocyte hypertrophy, type X collagen in normally expressed in human 
OA cartilage especially in the vicinity of lesions, but not in human healthy articular carti-
lage [107,108]. Hypertrophic chondrocytes express a variety of proteins and enzymes as 
type X collagen, matrix metalloproteinase 13 (MMP13), alkaline phosphatase, which do 
not seem to exit in normal proliferating chondrocytes [109]. These chondrocytes increase 
their volume and secrete a specialized ECM rich in type X collagen. This matrix attracts 
blood vessels and bone precursor cells leading to bone development, but also the process 
of endochondral ossification has been reported in cartilaginous tumors [110]. 
The biological function of type X collagen in thought to maintain tissue stiffness, reg-
ulate chondrocytes metabolism and interact with hypertrophic chondrocytes [106,111]. It 
also facilitates the process of calcification, the normal distribution of matrix vesicles and 
PG within the growth plate [13,111]. 
Considering that ECM surrounding chondrocytes mineralizes to be replaced by bone 
marrow and bone, it was suggested that collagen X may be associated with the minerali-
zation process [39]. Its expression at sites of chondrocyte hypertrophy and calcification 
suggest that type X collagen support endochondral bone growth and development during 
the degradation of ECM in cartilage [13,109]. 
Mutations of the COL10A1 gene are causative for the disease Schmid type metaph-
yseal chondrodysplasia (MCDS; MIM 156500) impeding endochondral ossification in the 
metaphyseal growth plate. This leads to growth deficiency and skeletal deformities with 
short limbs [31]. These mutations have been also considered key in spondylometaphyseal 
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dysplasia (SMD) which is a group of genetic skeletal disorders that show abnormal devel-
opment of spine and metaphysis of long tubular bones [112]. 
4.2.6. Type XII, XIV, XVI, XXII, and XXVII Collagens 
Type XII belong to the group of FACITs collagens. Immunohistochemistry, staining 
and fibrillogenesis studies showed that type XII collagen can be incorporated into type I 
collagen fibrils in dense connective tissues and bone [113]. Type XII collagen is associated 
with articular cartilage and growth plate region during rat forelimb development and 
may be necessary for microenvironment that support hyaline cartilage formation [13,113]. 
Type XII collagen was also described in the secretome of human passaged chondrocytes 
[114]. Type XIV collagen is a large, non-fibrillar ECM protein which also belong to the 
group of FACITs. Immunofluorescence localization showed that type XIV collagen was 
prominent at the ligament-bone junction, and in bovine cartilage. Type XIV collagen lo-
calizes relatively uniformly throughout the articular cartilage but is absent from growth 
plate regions [13]. Both, type XII and XIV collagens, are often found in areas of high me-
chanical stress, and have roles in fibrillogenesis and maintaining the integrity and me-
chanical properties of the tissue [115]. 
Type XVI and XXII collagens belong to the group of FACITs collagens. Type XVI 
collagen has been identified in the territorial matrix of the chondrocytes, associating with 
thin weakly banded collagen fibrils containing type II and XI collagen [116]. It may be 
incorporated into structurally and functionally discrete matrix aggregates in cartilage [13]. 
Type XXII collagen is expressed at the junction between synovial fluid and surface of ar-
ticular cartilage and associated with the extrafibrillar matrix in cartilage [117].  
Type XXVII collagen is a fibril-forming collagen. It is mainly localized at sites of tran-
sition from cartilage to bone, and in the matrix surrounding proliferative chondrocytes in 
the epiphyseal growth plate [118,119]. It is believed to play a key structural role in the 
ECM of the growth plate and is required for the organization of the proliferative zone 
[119]. 
4.3. Articular Collagen Types Synthetized in Pathological Processes 
Type I Collagen 
The collagen type I triple helix is formed as a heterotrimer by two α1(I) chains and 
one α2(I) chain [α1(I)2α2(I)], which are encoded by COL1A1 and COL1A2 genes [49,120]. 
Type I collagen is the most abundant collagen in the body. It forms more than 90% of 
the organic mass of bone and is the major collagen of tendons, skin, ligaments, cornea, 
and many interstitial connective tissues with the exception of very few tissues such as 
hyaline cartilage, brain and vitreous body [31,36]. It is synthesized in large quantities by 
fibroblasts, osteoblasts, and to a lesser extent by nearly all other tissue cells [36,121,122].  
This collagen is always incorporated into heterofibrils containing either type III col-
lagen in skin and reticular fibers, type V collagen in bone, tendon, cornea, and other tis-
sues, or in heterofibrils containing both collagens [36,123,124]. Type I/III collagen hetero-
fibrils are a constituent of reticular fibers of most parenchymal tissues such as lung, kid-
ney, liver, muscle, or spleen, with the exception of hyaline cartilage, brain and vitreous 
humor [125]. 
In most organs and notably in tendons and fascia, type I collagen provides tensile 
stiffness and in bone, it defines considerable biomechanical properties concerning load 
bearing, tensile strength, and torsional stiffness, ensuring the stability and integrity of the 
tissues [31]. In addition to its biomechanical properties, type I collagen is important as 
adhesive substrate for many cells and plays a major role in organ and tissue development, 
in cell migration, proliferation and differentiation, and in wound healing, tissue remodel-
ing and hemostasis [121]. 
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Type I collagen is generally used as a marker for fibrous connective tissue, bone, and 
dentin [126,127]. Fibrocartilage is different from articular hyaline cartilage due to the pres-
ence of type I collagen and the lower content of glycosaminoglycans [128]. Pathological 
and disorganized regeneration of tissue in a variety of organs after injury often results in 
deposition of excessive fibrotic tissue with inferior biomechanical properties, as occurs 
with articular cartilage, where fibrocartilage is created as repair tissue [128,129]. Full-
thickness disruption of articular cartilage by trauma to synovial joints is one example in 
which highly specialized hyaline cartilage is replaced by biomechanically inferior, disor-
ganized fibrotic tissue enriched in collagen type I [130]. 
As mentioned above, hyaline articular cartilage contains type II collagen, fibrocarti-
lage contains a mixture of type I and II collagens, and fibrous tissue contains type I colla-
gen [127–129,131,132]. In this way, type II collagen cannot be used solely to determine 
whether a cartilage is hyaline type, since it can be also found in fibrocartilage, so it would 
be necessary to determine no type I collagen absence [133]. 
Mutations in the genes COL1A1 and COL1A2 cause of most cases of osteogenesis im-
perfecta. It is a heterogeneous hereditary disorder of bone matrix formation and remod-
eling that causes bone fragility and deformity, blue sclera, short structure, dentinogenesis 
imperfecta, and hearing loss [134,135]. 
4.4. Collagens in Pathological Situations 
OA is a disease that is often associated with age, female gender, obesity, muscle 
weakness, and joint injuries [136]. This disease transforms the main collagen of the artic-
ular cartilage, type II collagen, into a mixture of type I, II and III collagens. It can induce a 
100-fold upregulation of type I collagen and 6-fold of type III collagen, and a 5-fold down-
regulation of type II collagen [128]. Additionally, it was reported that a higher amount of 
type VI collagen is found in osteoarthritic cartilage that could be a consequence of a pro-
tective effect for chondrocytes [137]. Other authors also described an increase in type III 
and VI collagen in osteoarthritic articular cartilage, however they observed that a greater 
amount of type II collagen is also deposited [137,138]. 
The wound-healing role of major and minor collagens likely to play during the artic-
ular regeneration has not been completely deciphered, thus, more efforts should be made 
to elucidate this potential role. 
5. Role of Collagen Fibrils in the Quality of Repaired Tissue in Chondral Defects 
As mentioned above, the healthy articular cartilage is characterized by presenting a 
hyaline structure. Several authors have reported that using different current therapies for 
chondral lesions they have been able to obtain a hyaline-like repair tissue [139–142]. Thus, 
in this context, the basic question that is often asked regarding the cartilage regeneration 
after damage is about the role of all collagen types in the repair assessment, and the thresh-
old to consider a regenerated cartilage as hyaline-like cartilage including ECM evaluation. 
When evaluating the quality of a repaired cartilage, must be assessed the morpho-
logical and structural characteristics of the repaired regenerated tissue must be, and the 
presence and arrangement of collagens in the ECM. 
5.1. Methods of Cartilage Tissue Reparation 
There are several therapeutic modalities that aim to reduce pain and restoring carti-
lage function. These strategies can be medical treatments such as pharmacological ther-
apy, or surgical treatments such as palliative therapies (eg, chondroplasty and debride-
ment), repair techniques (eg, drilling and microfracture), restorative techniques (eg, tissue 
engineering) or prosthetic replacement [90,142–147]. 
Debridement is used to reduce pain; however, there is no obvious physiological or 
pathological evidence to show that it is beneficial for cartilage repair [148]. Perforation 
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and microfracture repair techniques are considered first-line treatments given their mini-
mally invasive nature, technical ease, and low cost [142,143]. They can be used alone or in 
combination with other tissue engineering techniques [149]. Tissue engineering seeks to 
repair damaged cartilage by introducing an optimized combination of cells, scaffold, and 
bioactive factors that can be transplanted into a patient [150]. Biomaterial scaffolds or hy-
drogel are being made with collagens given their ability to promote cartilage formation, 
the most common being type I and II collagen hydrogels [151,152]. Some of the techniques 
most frequently used in tissue engineering to repair chondral defects are autologous chon-
drocyte implantation, osteochondral autograft transfer and osteochondral allograft 
[143,145]. 
Despite the large number of methods that exist to treat chondral defects, they cannot 
restore a normal cartilage, and one of the main limitations in fibrocartilage formation 
without lasting improvements [19,145]. Much information is unknown about the intrinsic 
repair processes of damaged cartilage, and consequently the search for a treatment that 
would restore normal articular cartilage. For this reason, it is so important to evaluate in 
depth the repair quality of the repaired cartilage, including an exhaustive assessment of 
collagens. 
5.2. Methods for Evaluating Morphological and Structural Characteristics of a Repaired 
Cartilage 
The assessment of the morphological and structural characteristics is carried out with 
histopathological techniques such us HE staining, toluidine blue and Safranin O/fast 
green staining. 
There are several histopathological evaluation methods that help us determine how 
similar repaired cartilage is compared to healthy cartilage [131,133,153,154]. These are de-
tail studies that allow us to obtain standardized assessment methods. In summary, all of 
them and most authors agree that therapies aimed at developing successful hyaline carti-
lage regeneration should obtain a smooth surface predominantly rounded, lagoon-orga-
nized chondrocytes of low cell density a repaired tissue capable of integrating with living 
native cartilage, and good condition of subchondral bone [11,15,17,24,25,155]. 
5.3. Methods Allowing Evaluating Collagen of a Repaired Cartilage 
Collagens have been visualized using a variety of techniques, but the most common 
are histopathologic techniques because of they are less expensive and sample preparation 
is less complicated [131]. Toluidine blue and picrosirius red staining are the most widely 
used. It is important to observe these sections stained with polarized light to view the 
orientation of the collagen fibers [131,156,157]. In addition, it is very common to use im-
munohistochemical techniques that allow us to visualize the presence and location of a 
certain collagen in the cartilage. Immunohistochemically marked tissues are observed un-
der an optical microscope [90,133]. Despite involving a more complicated preparation and 
being more expensive, some authors use transmission electron microscopy, atomic force 
microscopy or structural illuminating microscopy, obtaining a higher resolution visuali-
zation of collagen fibers [142,157,158]. 
Regarding assessment methods, there is no standardized evaluation that determine 
the intrinsic quality of all collagen types in the repaired cartilage. Some of the previously 
mentioned methods [131,133,153,154], make a brief reference to the main collagens (type 
II, IX, and XI collagens), but there is a lack of information in considering the rest of the 
collagens contained in the articular cartilage to evaluate the quality of the repair and 
whether this repaired tissue can be considered as hyaline cartilage. 
Therefore, based on the information reported in several studies [3,12–
14,24,50,51,56,74–76,79,82,90,95,102,106–108,113–119,127,128,130–133], the composition of 
main and minor collagen types in ECM to consider the quality of a repaired cartilage as 
hyaline-type cartilage should be: 
• Main collagens: 
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- 90–95% type II collagen distributed throughout all areas of the ECM.  
- 1–5% type IX collagen distributed throughout all areas of the ECM. 
- 1–5% type XI collagen distributed throughout all areas of the cartilage and 
around the chondrocytes. 
• Minor collagens: 
- 1–2% type VI collagen distributed around the chondrocytes. 
- 1% type X collagen present only in the calcified area. 
- Presence of type IV and V collagen around the chondrocytes. 
- Possible presence of type III, XII, XIV, XVI, XXII, and XXVII collagens. 
• Absence of type I collagen. 
6. Conclusions 
There are many types of collagens present in the articular cartilage, both main and 
minor collagens, all of which are crucial for maintaining cartilage health. To accurately 
determine the repair tissue quality after a chondral lesion, the complete structure of the 
repaired cartilage tissue, including cells and their environment and main and minor col-
lagen types in ECM, should be included in the histopathological evaluation methods. 
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Abbreviations 
ECM  Extracellular matrix 
FACITs  Fibril-associated collagens with interrupted tripled helices 
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MMP13  Matrix metalloproteinase 13 
OA  Osteoarthritis 
PCM  Pericellular matrix 
PG  Proteoglycan 
RER  Rough endoplasmic reticulum 
SMD  Spondylometaphyseal dysplasia 
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